Targeted Treatments for Hormone Receptor-Positive Breast Cancer
There were some noteworthy developments this year in targeted therapies for hormone receptor-positive breast cancer.
Category: Research Updates
Breast Cancer Treatment: The TAILORx Clinical Trial
Findings from the TAILORx clinical trial will help personalize treatment decisions for many patients with early stage breast cancer.
5 Cancer Research Stories Worth Following – Spring 2018
Researchers are working on ways to make immune system therapies more effective for more cancer patients.
5 Cancer Research Stories Worth Following – Winter 2018
Cancer research stories worth following this winter included reports on new approaches to immunotherapy currently being tested in clinical trials.
5 Cancer Research Stories Worth Following – Fall 2017
Recent cancer research stories worth following include a study on post-traumatic stress disorder after a cancer diagnosis.
5 Cancer Research Stories Worth Following – Summer 2017
Two FDA approvals for immunotherapy treatments highlight cancer research news this summer. But the extremely high costs of new cancer therapies are yet to be addressed.
A Role for Progesterone in Breast Cancer Treatment?
New clinical trials will test whether the addition of progesterone could improve treatment for hormone receptor-positive breast cancer.
5 Cancer Research Stories Worth Following – Spring 2017
Cancer research stories worth following this spring include a study on the benefits of one type of immune system therapy for patients with metastatic triple negative breast cancer.
5 Cancer Research Stories Worth Following – Winter 2017
Cancer research stories worth following this winter include a possible new use for an existing drug to prevent metastasis in triple negative breast cancer.
5 Cancer Research Stories Worth Following – Fall 2016
Cancer research stories worth following this fall include new developments in targeted treatment for ovarian cancer and for metastatic breast cancer.
